NASDAQ

Cardiol Therapeutics Inc. - Class A Common Shares (CRDL)

336 Thanks from members

Cardiol Therapeutics Inc. (CRDL) maintains a stable market presence as a Nasdaq-listed Class A Common Share entity, trading around $1.78 with a market capitalization of approximately $207 million, drawing steady technical and financial tracking.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →